Immuneering Corporation Other Current Liabilities
Immuneering Corporation (IMRX) had Other Current Liabilities of $214.46 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Current $214.46K.
- 2026-03-31: Other Liabilities, Current $44.19K.
- 2025-12-31: Other Liabilities, Current $291.51K.
- 2025-09-30: Other Liabilities, Current $80.09K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $214.46K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $44.19K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $291.51K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $80.09K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $209.71K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $56.53K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $233.66K 10-K · filed 2026-03-06 |
| 2024-09-30 | $59.66K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $90.24K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $23.63K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $259.77K 10-K · filed 2025-03-20 |
| 2023-09-30 | $80.50K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $26.33K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $26.33K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $19.80K 10-K · filed 2024-03-01 |
| 2022-09-30 | $44.56K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $47.21K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $47.21K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |